Amit Gupta Sells 6,725 Shares of Cardlytics, Inc. (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CEO Amit Gupta sold 6,725 shares of the firm's stock in a transaction dated Wednesday, July 2nd. The shares were sold at an average price of $1.78, for a total value of $11,970.50. Following the sale, the chief executive officer owned 378,704 shares in the company, valued at $674,093.12. The trade was a 1.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Cardlytics Trading Up 3.6%

Shares of NASDAQ:CDLX traded up $0.07 on Friday, reaching $1.87. 720,336 shares of the company traded hands, compared to its average volume of 999,467. The stock has a market capitalization of $97.91 million, a P/E ratio of -0.52 and a beta of 1.21. The business's 50-day simple moving average is $1.81 and its 200 day simple moving average is $2.38. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 2.62. Cardlytics, Inc. has a 52 week low of $1.22 and a 52 week high of $9.48.

Institutional Investors Weigh In On Cardlytics

Several institutional investors have recently bought and sold shares of the stock. Charles Schwab Investment Management Inc. increased its stake in Cardlytics by 3.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 402,552 shares of the company's stock worth $1,493,000 after purchasing an additional 12,209 shares during the period. Brooktree Capital Management boosted its stake in shares of Cardlytics by 4.5% during the fourth quarter. Brooktree Capital Management now owns 175,210 shares of the company's stock valued at $650,000 after purchasing an additional 7,568 shares during the period. Intech Investment Management LLC grew its holdings in shares of Cardlytics by 31.3% in the fourth quarter. Intech Investment Management LLC now owns 19,310 shares of the company's stock worth $72,000 after purchasing an additional 4,607 shares during the last quarter. Virtu Financial LLC purchased a new position in shares of Cardlytics in the fourth quarter worth $62,000. Finally, Geode Capital Management LLC increased its stake in shares of Cardlytics by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 1,060,739 shares of the company's stock worth $3,936,000 after buying an additional 7,561 shares during the period. 68.10% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Needham & Company LLC reiterated a "hold" rating on shares of Cardlytics in a research report on Thursday, March 13th. Evercore ISI cut their target price on Cardlytics from $4.00 to $3.00 and set an "in-line" rating for the company in a research note on Thursday, March 13th. Finally, Lake Street Capital decreased their price target on shares of Cardlytics from $3.00 to $2.50 and set a "hold" rating on the stock in a research note on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $3.50.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.